Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106009843 | 10600984 | 3 | F | 20160628 | 20141124 | 20160713 | EXP | IN-CIPLA LTD.-2014IN02069 | CIPLA | ST-ONGE M, DUBE PA, GOSSELIN S, GUIMONT C, GODWIN J, ARCHAMBAULT PM ET AL.,. TREATMENT FOR CALCIUM CHANNEL BLOCKER POISONING:A SYSTEMATIC REVIEW. CLINICAL TOXICOLOGY. 2014;52:926 TO 944 | 0.00 | Y | 0.00000 | 20160713 | OT | CA | IN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106009843 | 10600984 | 1 | PS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 280 MG, (56 TABLETS OF 5 MG EACH) | U | U | 206367 | 280 | MG | TABLET |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 106009843 | 10600984 | LT |
| 106009843 | 10600984 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 106009843 | 10600984 | Abdominal pain | |
| 106009843 | 10600984 | Acute lung injury | |
| 106009843 | 10600984 | Anxiety | |
| 106009843 | 10600984 | Intentional overdose | |
| 106009843 | 10600984 | Metabolic acidosis | |
| 106009843 | 10600984 | Nausea | |
| 106009843 | 10600984 | Shock | |
| 106009843 | 10600984 | Somnolence | |
| 106009843 | 10600984 | Suicide attempt | |
| 106009843 | 10600984 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |